(Q36495283)

14 August 2017

1 reference

title

Update on guidelines for the treatment of chronic musculoskeletal pain (English)

1 reference

14 August 2017

0 references

0 references

Thomas J Schnitzer

1

1 reference

14 August 2017

2 June 2006

1 reference

14 August 2017

Clinical Rheumatology

1 reference

14 August 2017

25 Suppl 1

1 reference

14 August 2017

S22-9

1 reference

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

14 August 2017

1 reference

12 December 2020

FDA issues public health advisory recommending limited use of COX-2 inhibitors

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

12 December 2020

Risk factors for adverse events in analgesic drug users: results from the PAIN study

1 reference

12 December 2020

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial

1 reference

12 December 2020

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials.

1 reference

12 December 2020

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs for low back pain.

1 reference

12 December 2020

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group

1 reference

12 December 2020

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use.

1 reference

12 December 2020

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

1 reference

12 December 2020

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

12 December 2020

Epidemiology of osteoarthritis in Australia.

1 reference

12 December 2020

The epidemiology of chronic pain in the community

1 reference

12 December 2020

Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo

1 reference

12 December 2020

Glucosamine therapy for treating osteoarthritis

1 reference

12 December 2020

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

1 reference

12 December 2020

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

1 reference

12 December 2020

RETRACTED: Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group

1 reference

12 December 2020

10.1007/S10067-006-0203-8

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16741783